Neogenesis Biotech continuously optimizes TIL (Tumor Immersed Lymphoid) detection processes, integrating multicolor flow cell analysis, AI Cell Report and tumor immunoassay technologies to create a more accurate and consistent tumor immune microenvironment assessment platform to support cell therapy, immunological research and precision medical development.
In recent years, cell therapy has emerged as a key frontier in regenerative medicine. However, not every patient is a candidate for the same type of treatment.
Neogenesis Biotech partners with Taipei Veterans General Hospital to advance clinical research by integrating cellular analysis, clinical data, and AI-powered analytics. This collaboration aims to deepen precision medicine research, accelerate the translation of scientific discoveries into clinical practice, and support the development of more personalized and effective healthcare solutions.
.svg){kind=small}
